In RA study IV, the ACR 20 response of patients treated with Humira plus standard of care was statistically significantly better than patients treated with placebo plus standard of care (p < 0.001).
Nivelreumatutkimuksessa IV Humiraa ja standardihoitoa saaneiden potilaiden ACR 20- vaste oli tilastollisesti merkitsevästi parempi kuin plaseboa ja standardihoitoa saaneiden (p < 0, 001).